XBiotech Inc. — Director's Dealing 2019

Mar 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2019-03-04

Reporting Person: RENNES FONDATION (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-03-04	Common Stock	P	16426	$7.91	Acquired	3910282	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.80 to $8.04, inclusive. The reporting person undertakes to provide to XBiotech Inc., any security holder of XBiotech Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.